Big pharma groups are snapping up biotechs at a record pace as they race to bolster their drug pipelines, spend windfalls ...

VERAXA Biotech (NASDAQ: VRXA) announced it has received Scientific Advice from Germany’s Paul-Ehrlich-Institute ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Beam Therapeutics' growing pipeline could reward patient investors.

Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...

On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, ...

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

The University of Pittsburgh announced an agreement with biotech company MitoSense Inc. to research opportunities in space ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...